Seagen, a large-cap None stock, moved -0.2% this evening. Here are some facts about the company that we're keeping an eye on:
-
Seagen has logged a 74.0% 52 week change, compared to 14.0% for the S&P 500
-
SGEN has an average analyst rating of hold and is -7.07% away from its mean target price of $228.91 per share
-
Its trailing earnings per share (EPS) is $-4.0, which brings its trailing Price to Earnings (P/E) ratio to -53.2. The Health Care sector's average P/E ratio is None
-
The company's forward earnings per share (EPS) is $-1.97 and its forward P/E ratio is -108.0
-
The company has a Price to Book (P/B) ratio of 15.73 in contrast to the Health Care sector's average P/B ratio is None
-
The company's free cash flow for the last fiscal year was $-701211000 and the average free cash flow growth rate is -20.9%
-
Seagen's revenues have an average growth rate of None% with operating expenses growing at None%. The company's current operating margins stand at -32.1%